Ginkgo Bioworks Holdings's total assets for Q4 2024 were $1.38B, a decrease of -6.98% from the previous quarter. DNA total liabilities were $661.39M for the fiscal quarter, a -3.16% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.